Navigation Links
Par Pharmaceutical Companies Reports Adjusted EPS of $0.65 for Fourth Quarter 2009
Date:2/24/2010

r press release and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein.  Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's Annual Report on Form 10-K in other of the Company's filings with the SEC from time to time, including Current Reports on Form 8-K, and on general industry and economic conditions.  Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.

    
    
                           PAR PHARMACEUTICAL COMPANIES, INC.
                          CONSO
'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
2. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
3. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
4. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
5. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
6. Innovative University of Cincinnati Program Trains Next Generation of Pharmaceutical Professionals
7. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
8. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
9. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
10. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
11. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 GenomeDx Biosciences today ... the American Society for Radiation Oncology (ASTRO) Annual ... Cancer Classifier, a genomic test capable of predicting ... and improve patient outcomes for prostate cancer patients ... a recently published study that demonstrates how Decipher ...
(Date:9/15/2014)...  Alere Inc. (NYSE: ALR ) (the ... toxicology, cardiology and diabetes products and services, today confirmed ... CEO Ron Zwanziger , filed a Schedule 13D ... a letter to Gregg J. Powers , Chairman ... in an effort to secure financing to make a ...
(Date:9/15/2014)... Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. ... pharmaceutical company with a focus on Omega-3 therapies ... that the Board of Directors approved the granting ... advisor at the close of business on Friday, September ... 1,000,000 common shares of the Company were granted ...
Breaking Medicine Technology:Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Alere Responds To Letter From Former Executives 2Pivotal Therapeutics Grants Incentive Stock Options 2
... May 9, 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: ... abstracts at the 2011 Digestive Disease Week (DDW) conference ... of DIFICID™ (fidaxomicin), an investigational product for the treatment ... (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) The first analysis ...
... Australia and BEIJING, May 9, 2011 Saladax Biomedical, ... diagnostic assays to achieve the promise of personalized medicine ... of its Pacific Rim commercialization team to expand its ... Saladax,s Pacific Rim commercialization team include: ...
Cached Medicine Technology:Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 2Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 3Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 4Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China 2
(Date:9/15/2014)... MONDAY, Sept. 15, 2014 (HealthDay News) -- U.S. heart ... an electrocardiogram (ECG) when evaluating young people for underlying ... The American Heart Association and the American College ... more detailed personal and family medical history along with ... genetic or congenital (existing from birth) risks for sudden ...
(Date:9/15/2014)... (PRWEB) September 16, 2014 “Canada ... market data on the Canada Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Female Sterilization Devices (Transcervical Sterilization Devices ... Rings) , Endometrial Ablation Devices (Thermal ...
(Date:9/15/2014)... Maureen Salamon HealthDay ... -- Pediatricians prescribe antibiotics about twice as often as ... infections, a new study indicates. More than 11 ... teens may be unnecessary, according to researchers from University ... use not only fails to eradicate children,s viral illnesses, ...
(Date:9/15/2014)... 15, 2014 As Colorado's historic ... its first full year, there are a variety ... in the evolution of its marketing and branding. ... taken by Denver's Kindman, one of the state's ... , Kindman has pioneered the first-ever branded and ...
(Date:9/15/2014)... Physicians and clinicians from around ... at the Lowes Coronado Bay Resort for the ... . This CME accredited medical conference ... healthcare professionals—about the nutritional science that overwhelmingly supports ... its proven ability to prevent, suspend and, often, ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3
... the Netherlands have identified a chemical agent that may ... syndrome (BOS), or popcorn workers lung, a severe occupational ... an American plant that makes microwaveable popcorn. ... at a chemical plant that produced diacetyl (a key ...
... the way toward screening people at risk for lung ... researchers from the University of Colorado say. , The ... prevention, said researcher Wilbur A. Franklin, M.D., Professor of ... Our goal would be to develop screening techniques for ...
... the Board, SAN DIEGO, Aug. 30 ResMed ... of directors has unanimously approved a,succession plan for executive ... Gallahue will be promoted to Chief Executive Officer and,will ... succeed Dr. Peter,C. Farrell, 65. As of January 1, ...
... The United States,Government, through the U.S. Agency for ... million in equipment and technical,assistance to the Government ... country. This announcement follows the provision of an ... the Hellenic Red Cross for emergency,fire fighting equipment ...
... grants 1500 Caregivers, members of SEIU UHW-West and 121RN, ... and classification at hospital, BURBANK, Calif., Aug. 30 ... members of SEIU United Healthcare Workers -,West (UHW) and ... Providence St. Joseph Medical Center. The contract, which expires,Sept. ...
... Four-Star,General Barry McCaffrey (ret), former White House National Drug ... International,Affairs and a widely cited terrorism and drug policy ... Chair of a State Capitol rally for,recovery and treatment ... at,11:30. Also speaking will be California HHS Secretary ...
Cached Medicine News:Health News:Chemical culprit in 'popcorn worker's lung' identified 2Health News:New technique detects specific chromosomal damage, may indicate lung cancer risk 2Health News:ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008. 2Health News:Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract 2Health News:4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote 'Recovery Happens!' Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento 2
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Simplicity and multi-directional retraction for a broad range of abdominal procedures...
These retractors are packaged singly ready for sterilization at your facility....
These retractors are packaged singly ready for sterilization at your facility....
Medicine Products: